GILEAD SCIENCES, INC.'s Net Worth
Estimate Recalculated Jun 18, 2025 08:57PM EST
Who is GILEAD SCIENCES, INC.
GILEAD SCIENCES, INC. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Arcus Biosciences, Inc., HOOKIPA Pharma Inc., Jounce Therapeutics, Inc., ACHILLION PHARMACEUTICALS INC, Allovir, Inc., ASSEMBLY BIOSCIENCES, INC., Kyverna Therapeutics, Inc., Arcellx, Inc., Xilio Therapeutics, Inc., and LEAP THERAPEUTICS, INC..
SEC CIK
GILEAD SCIENCES, INC.'s CIK is 0000882095
Past Insider Trading and Trends
2024 was GILEAD SCIENCES, INC.'s most active year for acquiring shares with 7 total transactions. GILEAD SCIENCES, INC.'s most active month to acquire stocks was the month of May. 2006 was GILEAD SCIENCES, INC.'s most active year for disposing of shares, totalling 2 transactions. GILEAD SCIENCES, INC.'s most active month to dispose stocks was the month of January. 2024 saw GILEAD SCIENCES, INC. paying a total of $343,339,058.76 for 24,090,914 shares, this is the most they've acquired in one year. In 2024 GILEAD SCIENCES, INC. cashed out on 14,636,883 shares for a total of $0.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
